Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 1082 for “"Neuroblastoma"”.
-
Novel Neuroblastoma Differentiating Agents
Neuroblastoma (NB) is the 3rd most lethal pediatric cancer. In high-risk patients, the 5-year survival rate is 40-50% after treatment. The differentiation therapy with retinoic acid (RA) is at the forefront of approaches to treat neuroblastoma; however, more than half of patients experience …
-
Efeito da estimulação magnética estática em linhagem celular de neuroblastoma e neuroblastoma diferenciado
… magnéticos não interajam entre si. As células de neuroblastoma humano SH-SY5Y foram plaqueadas 1x106 células por poço e cultivadas em placas de 24 poços. A análise microscópica das placas demonstrou que as células adaptaram-se ao novo ambiente, demonstrando aderência e crescimento adequados à …
-
PRUSSIAN BLUE NANOIMMUNOTHERAPIES FOR NEUROBLASTOMA
Neuroblastoma is the most common extracranial solid tumor in children, accounting for 15% of cancer-related deaths. Despite improvements in diagnosis and surgical techniques, neuroblastoma remains challenging to treat due to the heterogeneity of the tumor, low neoantigen expression, …
-
Advancing quantitative imaging of neuroblastoma
Neuroblastoma is an embryonal cancer that exhibits marked heterogeneity of presentation and prognosis, ranging in outcomes from amongst the poorest in paediatric oncology to spontaneous remission. Scintigraphy using ¹²³I-meta-Iodobenzylguanidine (MIBG) provides unique functional information and is …
-
Pathogenesis and treatment of neuroblastoma
Neuroblastoma (NB) is the most common extracranial solid tumor that occurs in children. NB is highly metastatic and varies in risk level according to tumor histology and genetic characteristics. The amplification of the MYCN oncogene is one of the key factors that promotes the development of tumors …
-
Suppression of neuroblastoma tumorigenesis using ENU mutagenesis in the Th-MYCN mouse model of neuroblastoma
Neuroblastoma, a disease of the neural crest and the most common solid tumour of infancy, accounts for 7-10% of all childhood cancer. The disease arises from primitive cells within the neural crest, and can develop at any point along the sympathetic nervous system, including sites within the …
-
Redox Regulation of Differentiation in Neuroblastoma
Neuroblastoma is the most common extracranial solid tumor in childhood, ranking third in prevalence among infant cancers. Despite intensive therapy with surgery, radiation and chemotherapy, there is a high chance of tumor recurrence. These children are therefore given retinoids in the maintenance …
-
Notch Signaling in Human Neuroblastoma Cells
Neuroblastoma is a childhood tumor derived from the sympathetic nervous system (SNS). It is believed that the tumors arise from cells halted in their differentiation and due to their immature phenotype; they express proteins normally only detected during embryogenesis. One such protein is Hash-1, …
-
Deciphering mechanisms of neuroblastoma drug resistance using single cell transcriptomics and developing targeted combination therapies for neuroblastoma
… comprise four histological subtypes, including neuroblastoma (NB). Half of high-risk NB patients relapse after chemotherapy, and relapsed patients seldom respond to therapy afterward. This study aimed to identify chemoresistance mechanisms and effective combination therapies against …
-
Polycationic nanoparticles for microRNA delivery in neuroblastoma
… solid extracranial tumor impacting children, neuroblastoma (NB) continues to be a cancer that garners interest into its mechanisms and its treatment. Current treatment strategies for low- and intermediate-risk NB are effective with good patient outcomes and overall survival rates above 95%. …
-
The Role of CDKN3 in Neuroblastoma Differentiation
No abstract prepared.
-
The role of lncRNA NKAPP1 in neuroblastoma
Neuroblastoma is a paediatric malignancy with heterogeneous clinical behaviour and a poor prognosis for high-risk disease. Emerging evidence suggests that long non-coding RNAs (lncRNAs) play key regulatory roles in cancer biology, including neuroblastoma pathogenesis. LncRNAs bind to DNA, RNA, or …
-
Investigation of Therapeutic Vulnerabilities in Metastatic Neuroblastoma
Survival for high-risk neuroblastoma (NB) remains poor. Most patients who recur present with metastatic disease, and few targetable pathways governing metastatic spread to distant sites are known, thus, novel approaches to target metastatic NB are required. We previously developed a metastatic …
-
Understanding the role of PRMT5 in neuroblastoma
Neuroblastoma (NB) is a deadly childhood cancer that has an orphan disease status, and the most malignant forms of the tumours have MYCN amplification. There is significant unmet medical need and urgency to develop new treatments for high-risk NB patients, as clinical research on rare diseases of …
-
Nutrition regimens for children with advanced neuroblastoma
This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).
-
Preclinical investigation of novel therapies against neuroblastoma
Neuroblastoma is a childhood tumor of the sympathetic nervous system and the most common tumor form diagnosed in infants. Patients with aggressive tumors are treated intensely with multi-modal therapy including chemotherapy, surgery, radiotherapy and immunotherapy. Despite this, many children …
-
Hypoxia and differentiation in human neuroblastoma cells
The childhood tumour neuroblastoma is derived from immature cells of the sympathetic nervous system, which have become arrested at different maturation stages. Neuroblastoma is a malignancy with a high degree of heterogeneity, and there is a correlation between a poor differentiation status and a …
Page 1 of 55